Rezultati pretraživanja
  1. prije 8 sati

    What's the cost of selecting the right ? Make sure you are aware of all of the tests possible and contact us if you need help getting recommended CROs and !

  2. 20. lip 2019.

    CCRM is excited to launch a brand new initiative. We are answering your Qs on a variety of topics related to working with ...and if you don't know these acronyms, you should definitely check it out!

  3. 19. ruj 2019.

    We are so very proud to share the news about our approval!! This achievement positions us at the level of the most distinguished in the world and represents a very important breakthrough in the history of 3P.

  4. 13. pro 2019.

    🌲🎁 Our is to provide to different companies, from start-ups to large companies, as well as to other , to help their products to reach the market

  5. 3. velj

    Discover insider information from a recent roundtable discussion about the use of and what companies are looking for from them and much more. Download your copy here

  6. 31. sij

    ‘Lack of good CDMOs’ factor for Krystal’s $90m gene therapy plant via

  7. 30. sij

    Lack of good a factor for in investing $70-90m into internal PA gene therapy plant

  8. 19. stu 2019.

    "Outsourcing is a very effective way for pharma companies to tap into additional formulation expertise.” Our Global VP Innovator Products and Solutions, Nick Shackley, examines the growing partnership between and in :

  9. On 12 November we organise with the workshop 'Technologies for improving bioavalilability of poorly water-soluble ' by Dr A. Loxley, consultant of (), one of the world's leading ▶️ Don't miss it! 👍

  10. 29. lis 2019.

    . interviewed Michel Lagarde, Executive VP of Thermo Fisher Scientific, about the challenges are facing as the pharma and markets rapidly grow.

  11. 23. lis 2019.

    Ready to use next-gen technology platforms and shift in portfolios from large volumes but simple, to lower volumes but complex or orphan molecules or even the lack of approved capacity for complex/sterile drugs are some reasons the have started to feel real +ve traction.

    Prikaži ovu nit
  12. 15. lis 2019.

    Pharma : long time veteran observer and good friend Jim Miller reflects on 20+ years’ learnings at

  13. The continues to grow and is estimated at $1.5 trillion by 2021. An important driver is the trend to development and manufacturing to . We have asked executives working in this market to share their experiences.

  14. 26. ruj 2019.

    Supply chain digitization creates new revenue opportunities in the vaccine market via

  15. 20. ruj 2019.

    In order to capitalize on the trend to outsource product development and manufacturing, need to continuously optimize their strategy by establishing and enforcing a value-based pricing concept. Our experts commented for .

  16. 5. kol 2019.

    "A good CDMO is not just about doing what they are told – the best are also consultants and collaborators.” Our Global VP Innovator Products and Solutions, Nick Shackley, shares his insights on partnerships between and in :

  17. 10. srp 2019.

    Useful info! Looking forward to watching the videos from . Thanks for sharing the news about 's new technical blogs that answer Qs about , , working with and more.

    Prikaži ovu nit
  18. 17. lip 2019.

    This week in pharma... mega impacting M&A, calls on help for T&T tech, costs a headache for regulators and more… 👇

  19. is tomorrow! We're sold out with lots of great speakers and insightful panel discussions. Registration is from 8am so see you then!

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.